Quick Answer
10x Genomics, Inc. reported Long Term Debt of $0.00 for the year ending 2020.
- 10x Genomics, Inc. showed a decrease of -100.0% in Long Term Debt from 2019 to 2020.
- This data is from 10x Genomics, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2021.
- XBRL data for this metric is available from 2018 to 2020 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $22.31 million | Q1 2020: $0.00 | Q2 2020: $0.00 | Q3 2020: $0.00.
- Over the full 3 years of available data (2018 to 2020), 10x Genomics, Inc.'s Long Term Debt has declined by 100.0%.
- Historical annual values: Fiscal year 2020: $0.00 | Fiscal year 2019: $19.84 million | Fiscal year 2018: $25.49 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: